Commercial roadmap

A portfolio-level commercialization model for oncology intelligence.

Programs may advance through research, validation, partner development, pilots, and commercial readiness depending on evidence, partner fit, and decision gates.

01

Discovery and Validation

  • Retrospective studies
  • Dataset and cohort definition
  • Model development
  • Clinical and technical validation
  • Identification of product opportunities
02

Workflow Integration

  • External validation
  • Multisite testing
  • Scanner and preparation variability
  • Clinical-workflow integration
  • Product target definition
03

Commercial Pilots

  • Partner-led pilots
  • Clinical-trial applications
  • Diagnostic workflow evaluation
  • Market and geography selection
  • Reimbursement and regulatory planning
04

Portfolio Expansion

  • Additional cancer indications
  • Longitudinal monitoring
  • Multimodal biomarker development
  • Drug-development applications
  • Licensed or jointly commercialized products